SCHEMBL12822381

SCHEMBL12822381

Nc1ncnc2c1sc1nc3ccccc3cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 7/20 0.59
▸ CLK1 P49759 10/20 0.58
▸ CDC7 O00311 3/20 0.58
▸ DBF4 Q9UBU7 2/20 0.58
▸ CHEK2 O96017 2/20 0.57
▸ FLT1 P17948 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ USP2 O75604 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ HPGD P15428 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ CDK5 Q00535 2/20 0.54
▸ CDK5R1 Q15078 1/20 0.54
▸ EEF2K O00418 1/20 0.52
▸ PI4KA P42356 1/20 0.46
▸ PI4K2B Q8TCG2 1/20 0.46
▸ PI4K2A Q9BTU6 1/20 0.46
▸ PI4KB Q9UBF8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23327861 0.83 CHEK2 (0.57) LIMK1CLK1CDC7DBF4CHEK2
SCHEMBL31683835 0.83 CHEK2 (0.57) LIMK1CLK1CDC7DBF4CHEK2
SCHEMBL23353057 0.75 CHEK2 (0.49) LIMK1CLK1CDC7DBF4CHEK2
SCHEMBL23353114 0.75 CHEK2 (0.49) LIMK1CLK1CDC7DBF4CHEK2
SCHEMBL23352787 0.75 CHEK2 (0.49) LIMK1CLK1CDC7DBF4CHEK2
SCHEMBL23352803 0.75 CHEK2 (0.49) LIMK1CLK1CDC7DBF4CHEK2
SCHEMBL4901470 0.74 LIMK1 (1.00) LIMK1CLK1CDC7DBF4KDM4E
SCHEMBL12970349 0.73 CLK1 (1.00) LIMK1CLK1CDC7DBF4
SCHEMBL31462912 0.73 CHEK2 (1.00) CLK1CHEK2FLT1KDM4ENPC1
SCHEMBL23458905 0.73 CHEK2 (1.00) CLK1CHEK2FLT1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012131297-A1 PYRIDO [3',2' :4,5] THIENO [3, 2-D] PYRIMIDIN- 4 - YLAMINE DERIVATIVES AND THEIR THERAPEUTICAL USE BAELL JONATHAN BAYLDON (AU) 2012-10-04 — — WO disclosed
Send feedback